MENU
+Compare
RGLS
Stock ticker: NASDAQ
AS OF
Jan 17 closing price
Price
$1.24
Change
-$0.04 (-3.12%)
Capitalization
81.22M

RGLS Regulus Therapeutics Forecast, Technical & Fundamental Analysis

a developer of pharmaceutical products

Industry Biotechnology
RGLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for RGLS with price predictions
Jan 08, 2025

RGLS in downward trend: price dove below 50-day moving average on January 07, 2025

RGLS moved below its 50-day moving average on January 07, 2025 date and that indicates a change from an upward trend to a downward trend. In of 52 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on January 07, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on RGLS as a result. In of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RGLS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 73 cases where RGLS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RGLS advanced for three days, in of 239 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 116 cases where RGLS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.936) is normal, around the industry mean (14.744). P/E Ratio (0.000) is within average values for comparable stocks, (88.252). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.853). RGLS has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (0.000) is also within normal values, averaging (264.079).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. RGLS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RGLS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
RGLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

RGLS is expected to report earnings to fall 17.95% to -17 cents per share on March 20

Regulus Therapeutics RGLS Stock Earnings Reports
Q4'24
Est.
$-0.17
Q3'24
Missed
by $0.04
Q2'24
Missed
by $0.05
Q1'24
Missed
by $0.07
Q4'23
Est.
$-0.40
The last earnings report on November 07 showed earnings per share of -20 cents, missing the estimate of -17 cents. With 330.14K shares outstanding, the current market capitalization sits at 81.22M.
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
4224 Campus Point Court
Phone
+1 858 202-6300
Employees
30
Web
https://www.regulusrx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMKR25.910.45
+1.77%
Amkor Technology
CYH3.060.05
+1.66%
Community Health Systems
WIMI1.110.01
+0.45%
WiMi Hologram Cloud
AMRX8.26-0.05
-0.60%
Amneal Pharmaceuticals
MRK97.92-2.78
-2.76%
Merck & Co

RGLS and Stocks

Correlation & Price change

A.I.dvisor tells us that RGLS and SPRY have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RGLS and SPRY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RGLS
1D Price
Change %
RGLS100%
-3.12%
SPRY - RGLS
28%
Poorly correlated
+3.20%
NAUT - RGLS
26%
Poorly correlated
+1.58%
FENC - RGLS
25%
Poorly correlated
-1.60%
IDYA - RGLS
25%
Poorly correlated
-2.38%
CARA - RGLS
25%
Poorly correlated
+1.09%
More